We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $37M
1-Year Est. Return 63.54%
This Fund
S&P 500
This Quarter Est. Return
+32.64%
1 Year Est. Return
+63.54%
3 Year Est. Return
+38.32%
5 Year Est. Return
+47.02%
10 Year Est. Return
+2,091.28%
AUM
$37M
AUM Growth
+$22.1M
Cap. Flow
+$13.6M
Cap. Flow %
36.81%
Top 10 Hldgs %
92.42%
Holding
19
New
2
Increased
2
Reduced
5
Closed
–
Avg Time Held
6.5 quarters
Top 10 Avg Time Held
3.3 quarters
Top 20 Avg Time Held
4.5 quarters

Top Buys

Rank Stock Value
1
ALMR icon
Alamar Biosciences
ALMR
+$17.1M
2
KO icon
Coca-Cola
KO
+$197K
3
MSFT icon
Microsoft
MSFT
+$4.05K
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.57K

Top Sells

Rank Stock Value
1
IMDX icon
Insight Molecular Diagnostics
IMDX
+$2.28M
2
CAI icon
Caris Life Sciences
CAI
+$1.15M
3
NTRA icon
Natera
NTRA
+$213K
4
NVDA icon
NVIDIA
NVDA
+$41.1K
5
BBNX icon
Beta Bionics
BBNX
+$1.02K

Sector Composition

Rank Sector Weight
1 Healthcare 90.44%
2 Technology 5.26%
3 Financials 1.19%
4 Communication Services 1.15%
5 Consumer Discretionary 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ALMR icon
1
Alamar Biosciences
ALMR
$1.77B
$20.5M 55.35%
+755,909
New +$17.1M
2026 Q2
0 quarters
BBNX icon
2
Beta Bionics
BBNX
$942M
$4.41M 11.91%
281,164
-86
-0% -$1.02K
2025 Q1
5 quarters
ESTA icon
3
Establishment Labs
ESTA
$1.75B
$3.86M 10.44%
45,000
– –
2018 Q3
31 quarters
IMDX icon
4
Insight Molecular Diagnostics
IMDX
$99.5M
$2.86M 7.73%
484,845
-462,289
-49% -$2.28M
2019 Q4
26 quarters
NVDA icon
5
NVIDIA
NVDA
$5.41T
$460K 1.24%
2,300
-200
-8% -$41.1K
2025 Q4
2 quarters
CAI icon
6
Caris Life Sciences
CAI
$8.83B
$454K 1.23%
25,500
-64,440
-72% -$1.15M
2025 Q2
4 quarters
JPM icon
7
JPMorgan Chase
JPM
$883B
$442K 1.19%
1,350
– –
2025 Q4
2 quarters
GOOG icon
8
Alphabet (Google) Class C
GOOG
$4.29T
$424K 1.15%
1,200
+10
+0.8% +$3.57K
2025 Q4
2 quarters
NTRA icon
9
Natera
NTRA
$57.9B
$407K 1.1%
1,500
-1,000
-40% -$213K
2022 Q4
14 quarters
ADI icon
10
Analog Devices
ADI
$198B
$397K 1.07%
1,000
– –
2025 Q4
2 quarters
ASML icon
11
ASML
ASML
$664B
$378K 1.02%
190
– –
2025 Q4
2 quarters
MSFT icon
12
Microsoft
MSFT
$4T
$373K 1.01%
1,000
+10
+1% +$4.05K
2025 Q4
2 quarters
OM icon
13
Outset Medical
OM
$73.3M
$360K 0.97%
83,333
– –
2025 Q1
5 quarters
AAPL icon
14
Apple
AAPL
$5.04T
$337K 0.91%
1,165
– –
2025 Q4
2 quarters
NSPR icon
15
InspireMD
NSPR
$22.5M
$315K 0.85%
450,517
– –
2023 Q2
12 quarters
MGX icon
16
Metagenomi Therapeutics
MGX
$34.4M
$315K 0.85%
264,391
– –
2024 Q1
9 quarters
AMZN icon
17
Amazon
AMZN
$2.77T
$262K 0.71%
1,100
– –
2025 Q4
2 quarters
LIN icon
18
Linde
LIN
$226B
$259K 0.7%
500
– –
2025 Q4
2 quarters
KO icon
19
Coca-Cola
KO
$390B
$203K 0.55%
+2,500
New +$197K
2026 Q2
0 quarters

Similar funds

MAM
Madryn Asset Management New York $36.9M AUM
GSEP
Golden State Equity Partners South Coast Metro, California $37.1M AUM 20.75% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $37.4M AUM 28.82% 1-Year Est. Return
XA
X Advisors Santa Maria, California $37.6M AUM
YEPI
Yorktown Energy Partners IX New York $36.1M AUM 16.72% 1-Year Est. Return
PEP
Pickering Energy Partners Houston, Texas $36M AUM 0.95% 1-Year Est. Return
CP
Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return
TP
Toronado Partners San Francisco, California $35.5M AUM 48.42% 1-Year Est. Return

Pura Vida Investments's Q2 2026 Portfolio in Review

As of Q2 2026, Pura Vida Investments held 19 positions worth $37M, up 149% from $14.9M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Pura Vida Investments deployed $13.6M of net new capital in Q2 2026, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Alamar Biosciences: 755,909 shares worth $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 81% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Insight Molecular Diagnostics, an estimated $2.28M trimmed.

  • Pura Vida Investments's largest Q2 2026 buy was Alamar Biosciences: 755,909 shares worth $20.5M.
  • Pura Vida Investments added most to Microsoft in Q2 2026, an estimated $4.05K increase.
  • Pura Vida Investments's biggest Q2 2026 reduction was Insight Molecular Diagnostics, cutting an estimated $2.28M.
  • Pura Vida Investments's ten largest holdings make up 92% of its $37M portfolio in Q2 2026.
  • Pura Vida Investments opened 2 new positions and closed 0 in Q2 2026.
  • Pura Vida Investments's portfolio value rose 149% quarter-over-quarter to $37M.

Based on Pura Vida Investments's 13F filing for Q2 2026, filed 13 Aug 2026.